nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00782	0.00782	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—ACKR2—Crohn's disease	0.00777	0.00777	CbGpPWpGaD
Alprenolol—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00769	0.00769	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00765	0.00765	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—ACKR2—Crohn's disease	0.0076	0.0076	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00748	0.00748	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00748	0.00748	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—ACKR2—Crohn's disease	0.00743	0.00743	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—MLN—Crohn's disease	0.00736	0.00736	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00727	0.00727	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—MLN—Crohn's disease	0.0072	0.0072	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00711	0.00711	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—MLN—Crohn's disease	0.00704	0.00704	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—MLN—Crohn's disease	0.00701	0.00701	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00696	0.00696	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ACKR2—Crohn's disease	0.00671	0.00671	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.0067	0.0067	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00658	0.00658	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00656	0.00656	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00641	0.00641	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—MLN—Crohn's disease	0.00637	0.00637	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00623	0.00623	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00609	0.00609	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00596	0.00596	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CCR6—Crohn's disease	0.0057	0.0057	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CCR6—Crohn's disease	0.00534	0.00534	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00518	0.00518	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCR9—Crohn's disease	0.0051	0.0051	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00507	0.00507	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—PTGER4—Crohn's disease	0.00501	0.00501	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCR9—Crohn's disease	0.00499	0.00499	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00496	0.00496	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCR9—Crohn's disease	0.00488	0.00488	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCR9—Crohn's disease	0.00486	0.00486	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—GPR65—Crohn's disease	0.00474	0.00474	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—GPR65—Crohn's disease	0.00464	0.00464	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00456	0.00456	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—GPR65—Crohn's disease	0.00454	0.00454	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—GPR65—Crohn's disease	0.00452	0.00452	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00446	0.00446	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00444	0.00444	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCR9—Crohn's disease	0.00441	0.00441	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.00437	0.00437	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00436	0.00436	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00434	0.00434	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.00428	0.00428	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00425	0.00425	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—MLN—Crohn's disease	0.00416	0.00416	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—GPR65—Crohn's disease	0.0041	0.0041	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—MLN—Crohn's disease	0.00407	0.00407	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ACKR2—Crohn's disease	0.00399	0.00399	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—MLN—Crohn's disease	0.00398	0.00398	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ACKR2—Crohn's disease	0.00397	0.00397	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00391	0.00391	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ACKR2—Crohn's disease	0.0039	0.0039	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00382	0.00382	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ACKR2—Crohn's disease	0.00381	0.00381	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MLN—Crohn's disease	0.00378	0.00378	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MLN—Crohn's disease	0.00376	0.00376	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00374	0.00374	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MLN—Crohn's disease	0.0037	0.0037	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MLN—Crohn's disease	0.00361	0.00361	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TAGAP—Crohn's disease	0.00344	0.00344	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCR6—Crohn's disease	0.00338	0.00338	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCR6—Crohn's disease	0.00331	0.00331	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCR6—Crohn's disease	0.00323	0.00323	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCR6—Crohn's disease	0.00322	0.00322	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RSPO3—Crohn's disease	0.00301	0.00301	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—PTGER4—Crohn's disease	0.00298	0.00298	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCR6—Crohn's disease	0.00292	0.00292	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—PTGER4—Crohn's disease	0.00291	0.00291	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR9—Crohn's disease	0.00288	0.00288	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SEL1L—Crohn's disease	0.00285	0.00285	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—PTGER4—Crohn's disease	0.00285	0.00285	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—PTGER4—Crohn's disease	0.00283	0.00283	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR9—Crohn's disease	0.00282	0.00282	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR9—Crohn's disease	0.00276	0.00276	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—GPR65—Crohn's disease	0.00268	0.00268	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—GPR65—Crohn's disease	0.00262	0.00262	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR9—Crohn's disease	0.00262	0.00262	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR9—Crohn's disease	0.00261	0.00261	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—PTGER4—Crohn's disease	0.00257	0.00257	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—GPR65—Crohn's disease	0.00256	0.00256	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR9—Crohn's disease	0.00256	0.00256	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR9—Crohn's disease	0.0025	0.0025	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—GPR65—Crohn's disease	0.00243	0.00243	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GPR65—Crohn's disease	0.00242	0.00242	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL3—Crohn's disease	0.00241	0.00241	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00241	0.00241	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00239	0.00239	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—GPR65—Crohn's disease	0.00238	0.00238	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ACKR2—Crohn's disease	0.00235	0.00235	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00233	0.00233	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—GPR65—Crohn's disease	0.00233	0.00233	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ACKR2—Crohn's disease	0.0023	0.0023	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.00229	0.00229	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ACKR2—Crohn's disease	0.00225	0.00225	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MLN—Crohn's disease	0.00223	0.00223	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL3—Crohn's disease	0.00219	0.00219	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MLN—Crohn's disease	0.00218	0.00218	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MLN—Crohn's disease	0.00213	0.00213	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—RASGRP1—Crohn's disease	0.00212	0.00212	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TAGAP—Crohn's disease	0.00204	0.00204	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TAGAP—Crohn's disease	0.002	0.002	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TAGAP—Crohn's disease	0.00195	0.00195	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR6—Crohn's disease	0.00191	0.00191	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR6—Crohn's disease	0.00187	0.00187	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CXCL8—Crohn's disease	0.00184	0.00184	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR6—Crohn's disease	0.00183	0.00183	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RSPO3—Crohn's disease	0.00178	0.00178	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RSPO3—Crohn's disease	0.00175	0.00175	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR6—Crohn's disease	0.00173	0.00173	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR6—Crohn's disease	0.00173	0.00173	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00172	0.00172	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	0.00171	0.00171	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR6—Crohn's disease	0.0017	0.0017	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SEL1L—Crohn's disease	0.00169	0.00169	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL2RA—Crohn's disease	0.00169	0.00169	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00168	0.00168	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.00166	0.00166	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	0.00166	0.00166	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SEL1L—Crohn's disease	0.00165	0.00165	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PTGER4—Crohn's disease	0.00165	0.00165	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	0.00162	0.00162	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.00161	0.00161	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RBX1—Crohn's disease	0.00156	0.00156	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR9—Crohn's disease	0.00155	0.00155	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL2RA—Crohn's disease	0.00154	0.00154	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PTGER4—Crohn's disease	0.00153	0.00153	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTGER4—Crohn's disease	0.00152	0.00152	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR9—Crohn's disease	0.00151	0.00151	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PTGER4—Crohn's disease	0.00149	0.00149	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR9—Crohn's disease	0.00148	0.00148	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	0.00146	0.00146	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GPR65—Crohn's disease	0.00144	0.00144	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL3—Crohn's disease	0.00143	0.00143	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00143	0.00143	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GPR65—Crohn's disease	0.00141	0.00141	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL3—Crohn's disease	0.0014	0.0014	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.0014	0.0014	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00139	0.00139	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GPR65—Crohn's disease	0.00138	0.00138	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	0.00137	0.00137	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—UBE2D1—Crohn's disease	0.00137	0.00137	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00137	0.00137	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00136	0.00136	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.00134	0.00134	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RIPK2—Crohn's disease	0.00133	0.00133	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00133	0.00133	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL3—Crohn's disease	0.0013	0.0013	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL3—Crohn's disease	0.00129	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL3—Crohn's disease	0.00127	0.00127	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00126	0.00126	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—RASGRP1—Crohn's disease	0.00125	0.00125	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL3—Crohn's disease	0.00124	0.00124	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—RASGRP1—Crohn's disease	0.00123	0.00123	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.0012	0.0012	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.0012	0.0012	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—JAK2—Crohn's disease	0.00114	0.00114	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SOCS1—Crohn's disease	0.00113	0.00113	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCL8—Crohn's disease	0.00109	0.00109	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—TYK2—Crohn's disease	0.00108	0.00108	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCL8—Crohn's disease	0.00107	0.00107	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	0.00104	0.00104	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCL8—Crohn's disease	0.00104	0.00104	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—JAK2—Crohn's disease	0.00103	0.00103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR6—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.00102	0.00102	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	0.001	0.001	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR6—Crohn's disease	0.001	0.001	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000982	0.000982	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR6—Crohn's disease	0.00098	0.00098	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SMAD3—Crohn's disease	0.00098	0.00098	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.00096	0.00096	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL8—Crohn's disease	0.000942	0.000942	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RBX1—Crohn's disease	0.000927	0.000927	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	0.000911	0.000911	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2RA—Crohn's disease	0.000907	0.000907	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RBX1—Crohn's disease	0.000907	0.000907	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	0.000902	0.000902	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	0.000891	0.000891	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RBX1—Crohn's disease	0.000886	0.000886	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	0.000883	0.000883	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000872	0.000872	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	0.000863	0.000863	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	0.000813	0.000813	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	0.000795	0.000795	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000792	0.000792	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	0.000788	0.000788	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000777	0.000777	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	0.000771	0.000771	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL3—Crohn's disease	0.000768	0.000768	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	0.000754	0.000754	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL3—Crohn's disease	0.000752	0.000752	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	0.000743	0.000743	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000742	0.000742	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL3—Crohn's disease	0.000735	0.000735	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	0.000727	0.000727	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000716	0.000716	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000711	0.000711	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	0.000675	0.000675	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	0.000673	0.000673	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	0.00066	0.00066	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	0.000659	0.000659	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000645	0.000645	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	0.000644	0.000644	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	0.000642	0.000642	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TYK2—Crohn's disease	0.000639	0.000639	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	0.000628	0.000628	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000616	0.000616	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	0.000614	0.000614	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	0.000613	0.000613	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—JAK2—Crohn's disease	0.00061	0.00061	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000602	0.000602	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	0.000599	0.000599	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000589	0.000589	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	0.000586	0.000586	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	0.000581	0.000581	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	0.000569	0.000569	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	0.000559	0.000559	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—Crohn's disease	0.000556	0.000556	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	0.000556	0.000556	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	0.000547	0.000547	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	0.000538	0.000538	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000535	0.000535	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—Crohn's disease	0.000529	0.000529	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	0.000527	0.000527	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	0.000515	0.000515	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—Crohn's disease	0.000447	0.000447	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TYK2—Crohn's disease	0.000379	0.000379	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TYK2—Crohn's disease	0.000371	0.000371	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TYK2—Crohn's disease	0.000363	0.000363	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—JAK2—Crohn's disease	0.000362	0.000362	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—JAK2—Crohn's disease	0.000354	0.000354	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—JAK2—Crohn's disease	0.000346	0.000346	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	0.00033	0.00033	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	0.000323	0.000323	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	0.000316	0.000316	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—Crohn's disease	0.000314	0.000314	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—Crohn's disease	0.000313	0.000313	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—Crohn's disease	0.000307	0.000307	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—Crohn's disease	0.0003	0.0003	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—Crohn's disease	0.000266	0.000266	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—Crohn's disease	0.00026	0.00026	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—Crohn's disease	0.000254	0.000254	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—Crohn's disease	0.000228	0.000228	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PTGS2—Crohn's disease	0.000199	0.000199	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—Crohn's disease	0.000186	0.000186	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—Crohn's disease	0.000181	0.000181	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—Crohn's disease	0.000177	0.000177	CbGpPWpGaD
